Skip to main content

Table 4 Statistical differences in the activity of XOR isoforms in PPPs between the studied groups (p-value)

From: Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy

XD in PPP

Gropus

P value

HD B vs TE B

0,04

HD B vs TE A

<0,001

HD A vs CT

0,044

HD A vs TE B

0,01

HD A vs TE B

<0,001

PD vs TE B

0,031

PD vs C

0,031

CKD vs TE B

0,005

TE A vs TE B

0,004

TE B vs C

0,005

TE A vs C

<0,001

XDO in PPP

Gropus

P value

HD B vs CKD

0,002

HD B vs C

<0,001

HD A vs CKD

<0,001

HD A vs TE B

0,014

HD A vs C

<0,001

PD vs CKD

0,02

PD vs C

0,001

CKD vs TE B

0,025

CKD vs TE A

<0,001

TE B vs TE A

0,011

TE B vs C

0,05

TE B vs C

<0,001

XO in PPP

Gropus

P value

HD B vs PD

<0,001

HD B vs TE B

<0,001

HD B vs TE A

0,008

HD A vs PD

0,042

HD A vs TE B

0,006

PD vs C

0,016

TE B vs C

0,002

TE A vs C

0,048